Skip to content
value.today

HyperBranch Medical Technology Inc

Total raised
$10 M
6 rounds on record
Latest round
$2 M
May 2012
First round on record
Jan 2009
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of HyperBranch Medical Technology Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2012$2 MNo. 6Under $2 million

HyperBranch Medical Technology Inc: Raise no. 6, May 2012

Investors in this round

8 investors had bought by the notice of Nov 28, 2012: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $4 M offered; $2 M still to sell
Smallest investment taken
$1,368
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$700,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeffrey G Clark · Executive Officer
  • John Conn · Executive Officer, Director
  • Aaron Jefferson Davidson · Director
  • B. Jefferson Clark · Director
  • Chris Jefferson Kroeger · Director
  • Michael Jefferson Wasserman · Director
  • Robert White · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by John Conn, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed Nov 28, 2012. Read the notice at the SEC.

equitySEC
Oct 2011$1 MNo. 5Under $2 million

HyperBranch Medical Technology Inc: Raise no. 5, Oct 2011

Investors in this round

7 investors had bought by the notice of Oct 20, 2011: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$250,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeffrey G Clark · Executive Officer
  • John Conn · Executive Officer, Director
  • Aaron Jefferson Davidson · Director
  • B. Jefferson Clark · Director
  • Chris Jefferson Kroeger · Director
  • Michael Jefferson Wasserman · Director
  • Robert White · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by John Conn, President and CEO. Source: SEC Form D, newest notice filed Oct 20, 2011. Read the notice at the SEC.

equitySEC
Nov 2010$2 MNo. 4$2 to $10 million

HyperBranch Medical Technology Inc: Raise no. 4, Nov 2010

Investors in this round

7 investors had bought by the notice of Nov 22, 2010: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Conn · Executive Officer, Director
  • Aaron Jefferson Davidson · Director
  • B. Jefferson Clark · Director
  • Bob JEFFERSON White · Director
  • Chris Jefferson Kroeger · Director
  • Michael Jefferson Wasserman · Director
  • Robert V. Toni · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by John Conn, President & CEO. Source: SEC Form D, newest notice filed Nov 22, 2010. Read the notice at the SEC.

equitySEC
Apr 2010$2 MNo. 3$2 to $10 million

HyperBranch Medical Technology Inc: Raise no. 3, Apr 2010

Investors in this round

7 investors had bought by the notice of Apr 19, 2010: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Conn · Executive Officer, Director
  • Aaron Jefferson Davidson · Director
  • B. Jefferson Clark · Director
  • Chris Jefferson Kroeger · Director
  • Michael Jefferson Wasserman · Director
  • Robert V. Toni · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by William N. Wofford, Assistant Secretary. Source: SEC Form D, newest notice filed Apr 19, 2010. Read the notice at the SEC.

equitySEC
Apr 2009$1 MNo. 2Under $2 million

HyperBranch Medical Technology Inc: Raise no. 2, Apr 2009

Investors in this round

3 investors had bought by the notice of May 12, 2009: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in De

People named in the notice

  • John Conn · Executive Officer, Director
  • Aaron Davidson · Director
  • B. Jefferson Clark · Director
  • Chris Kroeger · Director
  • Michael Wasserman · Director
  • Robert V. Toni · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by J. Robert Tyler, III, Assistant Secretary. Source: SEC Form D, newest notice filed May 12, 2009. Read the notice at the SEC.

equitySEC
Jan 2009$2 MNo. 1Under $2 million

HyperBranch Medical Technology Inc: Raise no. 1, Jan 2009

Investors in this round

3 investors had bought by the notice of Feb 25, 2009: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in De

People named in the notice

  • John Conn · Executive Officer, Director
  • Aaron Davidson · Director
  • B. Jefferson Clark · Director
  • Chris Kroeger · Director
  • Michael Wasserman · Director
  • Robert V. Toni · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by J. Robert Tyler, III, Assistant Secretary. Source: SEC Form D, newest notice filed Feb 25, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • HyperBranch Medical Technology Inc chose not to state its revenue in its newest notice of a funding round (Nov 2012).

    SEC Form D · Nov 2012

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Nov 2012

That is all the official record says: HyperBranch Medical Technology Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of HyperBranch Medical Technology Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 8 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by HyperBranch Medical Technology Inc
NameRoleNamed in
Jeffrey G ClarkExecutive officerNov 2012
John ConnExecutive officerNov 2012
Aaron Jefferson DavidsonDirectorNov 2012
B. Jefferson ClarkDirectorNov 2012
Chris Jefferson KroegerDirectorNov 2012
John ConnDirectorNov 2012
Michael Jefferson WassermanDirectorNov 2012
Robert WhiteDirectorNov 2012
Bob JEFFERSON WhiteDirectorNov 2010
Robert V. ToniDirectorNov 2010
Aaron DavidsonDirectorMay 2009
Chris KroegerDirectorMay 2009
Michael WassermanDirectorMay 2009